StockData
MapLight Therapeutics, Inc. logo

MapLight Therapeutics, Inc. (MPLT) stock

MPLTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$6.65+0.08 (+1.22%)

Close on Nov 18, 2026Market cap $308.41MP/E –Yield –

MapLight Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

MapLight Therapeutics's market cap was $339.87M on Nov 11, 2026, against $11.01M a year earlier.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$339.87M+2294.7%
2025Dec 31, 2025$14.19M–

More MapLight Therapeutics figures

See a number that looks wrong?